Top Markets
#1 DeFiChain DeFiChain +1,198.24%
#2 Superfortune Superfortune +102.78%
#3 V.I.T.R.I.O.L. Network V.I.T.R.I.O.L. Network +82.96%
#4 The Black Bull The Black Bull +80.59%
#5 Metaplex Metaplex +79.35%
#6 TokenOS AI TokenOS AI +59.62%
#7 Nexus Nexus +56.52%
#8 Alien Worlds Alien Worlds +55.53%
#9 Magma Finance Magma Finance +47.14%
#10 Hamster Kombat Hamster Kombat +36.70%
Coin of the day
DeFiChain DeFiChain
Paramètres
Langue
FRANçAIS
Devise
USD
Thème
Virbac SA Virbac SA

Virbac SA

VIRP
Classement en actions #3592
Virbac SA manufactures and sells a range of products and services for companion... Virbac SA manufactures and sells a range of products and services for companion and food-producing animals in France, Europe, Latin America, North America, the Asia Pacific, the Middle East, and Africa. The company offers a range of vaccines, dental hygiene, reproduction, dermatology, parasiticides, diagnostic, antibiotics, and aquaculture products; and veterinary medicines for anesthesia, geriatrics, behavior, and injectable micronutrients, as well as petfood and electronic identification. It serves veterinarians, farmers, and pet owners. Virbac SA was founded in 1968 and is headquartered in Carros, France.
Prix de l'action
$393.80
Capitalisation boursière
$3.30B
Changement (1 jour)
0.15%
Changement (1 an)
4.67%
Pays
FR
Échange Virbac SA (VIRP)

Catégorie

Healthcare
Ratio P/S pour Virbac SA (VIRP)
Ratio P/S au July 2026 TTM : 1.90
Selon les derniers rapports financiers et le cours de l'action de Virbac SA, le ratio cours/ventes actuel (TTM) est 1.90. À la fin de 2023, le ratio P/S était de 2.39.
Historique du ratio P/S pour Virbac SA de 2002 à 2026
Ratio P/S à la fin de chaque année
Année Ratio P/S Changez
2026 (TTM) 1.90 0.10%
2024 1.90 -20.75%
2023 2.39 51.21%
2022 1.58 -53.01%
2021 3.37 56.81%
2020 2.15 1.14%
2019 2.13 92.67%
2018 1.10 -8.14%
2017 1.20 -25.72%
2016 1.62 -25.62%
2015 2.17 14.35%
2014 1.90 6.88%
2013 1.78 -2.04%
2012 1.82 12.05%
2011 1.62 -17.65%
2010 1.97 45.76%
2009 1.35 19.90%
2008 1.13 -16.59%
2007 1.35 33.26%
2006 1.01 11.69%
2005 0.91 46.87%
2004 0.62 -14.23%
2003 0.72 7.76%
2002 0.67 0.00%
Ratio P/S pour des entreprises similaires ou concurrentes
Entreprise Ratio P/S Différence de Ratio P/S Pays
Eli Lilly Eli Lilly
Eli Lilly
LLY.US
15.63 721.94%
US
Johnson & Johnson Johnson & Johnson
Johnson & Johnson
JNJ.US
6.34 233.58%
US
AbbVie Inc. AbbVie Inc.
AbbVie Inc.
ABBV.US
7.07 271.80%
US
Merck & Co., Inc. Merck & Co., Inc.
Merck & Co., Inc.
MRK.US
4.84 154.22%
US
Novartis AG Novartis AG
Novartis AG
NVS.US
5.38 182.92%
CH